Health Care·NYSE·All covered stocks

DaVita Inc. (NYSE: DVA) Stock News & Analysis

DaVita Inc. (NYSE: DVA) is a healthcare company, listed on the NYSE. Alpha Stocks Insight has published 1 article on DVA since May 5, 2026, most recently "DaVita (NYSE: DVA) Beats Q1 Revenue Estimates, Raises Annual Profit Forecast" on May 5, 2026. Coverage to date spans Earnings Report, tracking DVA's earnings, analyst activity, and material corporate events. New coverage is added each trading day.

DVA Coverage -- 1 Article

Earnings Report·May 5, 2026

DaVita (NYSE: DVA) Beats Q1 Revenue Estimates, Raises Annual Profit Forecast

DVA gained 1.92% on Q1 beat and raised full-year guidance; dialysis demand remains resilient.

4 min readRead article

Important Legal Disclaimer

This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.

Affiliate disclosure: This site may contain affiliate links to brokerage platforms. If you open an account through one of our links, we may earn a commission at no additional cost to you. Affiliate relationships do not influence our editorial content or stock coverage decisions.

Important Legal Disclaimer: This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.

NYSE: DVA Stock News & Analysis -- DaVita Inc. | Alpha Stocks Insight